SUTRO BIOPHARMA, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Sutro Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Sutro Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$3.43M, a 139% decline year-over-year.
  • Sutro Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $138M, a 185% increase from 2022.
  • Sutro Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $48.3M, a 1384% increase from 2021.
  • Sutro Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3.26M, a 98.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $138M +$89.2M +185% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 $48.3M +$45.1M +1384% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $3.26M -$266M -98.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-25
2020 $269M +$273M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 -$4.18M -$175M -102% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $171M +$156M +1067% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 $14.6M +$14.5M +8170% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $177K Jan 1, 2016 Dec 31, 2016 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.